Safety of and chorioretinal circulation during repeated low-level red-light therapy for myopic children

Zhaoxin Jiang1, Shuyu Chen1, Renchun Wang1

  • 1State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Provincial Clinical Research Center for Ocular Diseases, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.

Insights

Repeated low-level red-light (RLRL) therapy is safe for children, showing fewer refractive errors. Continuous RLRL therapy enhances choroidal and retinal blood flow over time without adverse effects.

Area of Science:

  • Ophthalmology
  • Pediatric eye care
  • Visual science

Background:

  • Myopia progression in children is a significant concern.
  • Assessing the safety and efficacy of novel therapeutic interventions is crucial.
  • Understanding the impact of red-light therapy on ocular hemodynamics is an emerging area.

Purpose of the Study:

  • To evaluate the safety of repeated low-level red-light (RLRL) therapy in pediatric myopia.
  • To investigate the dynamic changes in choroidal and retinal blood flow during RLRL therapy.
  • To compare the effects of RLRL therapy plus single-vision spectacles (SVS) versus SVS alone.

Main Methods:

  • A single-center, randomized, single-blind, parallel-group clinical trial involving 70 myopic children.
  • Participants were assigned to either RLRL therapy plus SVS or SVS alone.
  • Ophthalmic examinations and optical coherence tomography angiography were used to assess refractive error, axial length, fundus structure, visual function, and microcirculation.

Main Results:

  • RLRL therapy significantly reduced increases in refractive error and axial length compared to SVS alone (p < 0.05).
  • No abnormalities in fundus structure or visual function were detected with RLRL therapy (p > 0.05).
  • Continuous RLRL treatment led to a time-dependent increase in choroidal and retinal circulation, peaking at 9 months, with a subsequent decline after cessation.

Conclusions:

  • Nine months of continuous RLRL exposure is safe for children, with no toxic side effects on retinal or optic nerve function.
  • RLRL therapy demonstrates a cumulative, time-dependent effect on enhancing choroidal and retinal circulation.
  • RLRL therapy shows promise as an effective intervention for myopia control in children.
Abstract

Related Concept Videos